---
$id: https://graph.org.ai/products/commodity/51282930
$type: Product
source: UNSPSC
code: "51282930"
title: "Miloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Miloxacin

**UNSPSC Code**: 51282930
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antibiotic with the molecular formula C12H9NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VM4W7043SN, chemically known as 5,8-dihydro-5-methoxy-8-oxo-2h-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid but generally known as miloxacin, which bears US NIH Compound Identifier 37614. European Medicines Agency schedules Miloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08967MIG. The term MILOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). MILOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule miloxacin under HS 29349990 and SITC 51579. As of Q4 2014, MILOXACIN remains the US FDA Preferred Term for this commodity. Miloxacin bears US NLM identifiers UMLS ID C0066553 and NCI Concept Code C66154. SMILES: O1C2C(OC1)CC1C(N(OC)CC(C1=O)C(=O)O)C2.

